Beatriz de Diego Diaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Beatriz de Diego Diaz has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Cristina Hajdu
Department of Biochemistry and Molecular Pharmacology, 2Department of Pathology, 3Department of Surgery, 4Department of Cell Biology, and 5New York University (NYU) Cancer Institute, NYU School of Medicine, New York, New York, USA
1 shared publication- David J. Cantor
Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
1 shared publication Francisco J. Peñas
Univ Navarra, Sch Sci, Dept Chem, E-31009 Pamplona, Spain
1 shared publicationGeorge Miller
Department of Biochemistry and Molecular Pharmacology, 2Department of Pathology, 3Department of Surgery, 4Department of Cell Biology, and 5New York University (NYU) Cancer Institute, NYU School of Medicine, New York, New York, USA
1 shared publication- Gregory David
Department of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, New York
1 shared publication - Juana Fernández-Rodríguez
Department of Environmental Technologies, IVAGRO, Faculty of Marine and Environmental Sciences (CASEM), University of Cadiz, Avenida República Saharaui, s/n, 11510 Puerto Real, Spain
1 shared publication
Latest Publications
- 1 January 2021
- Published by Elsevier in Journal of Cleaner Production
- Vol. 280
Sustainable management of lignocellulosic wastes: Temperature strategies for anaerobic digestion of artichoke
- 1 January 2021
- Published by Elsevier in Journal of Cleaner Production
- Vol. 280
Sustainable management of lignocellulosic wastes: Temperature strategies for anaerobic digestion of artichoke
- Open Access
- 1 April 2014
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 124 (5) , 2125-2135
Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Pancreatic ductal adenocarcinoma (PDAC) is strikingly resistant to conventional therapeutic approaches. We previously demonstrated that the histone deacetylase–associated protein SIN3B is essential for oncogene-induced senescence in cultured cells. Here, using a mouse model of pancreatic cancer, we have demonstrated that SIN3B is required for activated KRAS-induced senescence in vivo. Surprisingly, impaired senescence as the result of genetic inactivation of Sin3B was associated with delayed PDAC progression and correlated with an impaired inflammatory response. In murine and human pancreatic cells and tissues, levels of SIN3B correlated with KRAS-induced production of IL-1α. Furthermore, evaluation of human pancreatic tissue and cancer cells revealed that Sin3B was decreased in control and PDAC samples, compared with samples from patients with pancreatic inflammation. These results indicate that senescence-associated inflammation positively correlates with PDAC progression and suggest that SIN3B has potential as a therapeutic target for inhibiting inflammation-driven tumorigenesis.
- 1 April 2014
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 124 (5) , 2125-2135
Open AccessSenescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Pancreatic ductal adenocarcinoma (PDAC) is strikingly resistant to conventional therapeutic approaches. We previously demonstrated that the histone deacetylase–associated protein SIN3B is essential for oncogene-induced senescence in cultured cells. Here, using a mouse model of pancreatic cancer, we have demonstrated that SIN3B is required for activated KRAS-induced senescence in vivo. Surprisingly, impaired senescence as the result of genetic inactivation of Sin3B was associated with delayed PDAC progression and correlated with an impaired inflammatory response. In murine and human pancreatic cells and tissues, levels of SIN3B correlated with KRAS-induced production of IL-1α. Furthermore, evaluation of human pancreatic tissue and cancer cells revealed that Sin3B was decreased in control and PDAC samples, compared with samples from patients with pancreatic inflammation. These results indicate that senescence-associated inflammation positively correlates with PDAC progression and suggest that SIN3B has potential as a therapeutic target for inhibiting inflammation-driven tumorigenesis.